相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial
Faustino Torrico et al.
LANCET INFECTIOUS DISEASES (2018)
Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy
C. A. Morillo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Follow-up of an Asymptomatic Chagas Disease Population of Children after Treatment with Nifurtimox (Lampit) in a Sylvatic Endemic Transmission Area of Colombia
Fiorella Bianchi et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
EVALUATION OF THE ELISA-F29 TEST AS AN EARLY MARKER OF THERAPEUTIC EFFICACY IN ADULTS WITH CHRONIC CHAGAS DISEASE
Diana Fabbro et al.
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO (2013)
Impact of migration on the occurrence of new cases of Chagas disease in Buenos Aires city, Argentina
Guillermo Moscatelli et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2013)
Analytical Performance of a Multiplex Real-Time PCR Assay Using TaqMan Probes for Quantification of Trypanosoma cruzi Satellite DNA in Blood Samples
Tomas Duffy et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Adverse Events After the Use of Benznidazole in Infants and Children With Chagas Disease
Jaime Altcheh et al.
PEDIATRICS (2011)
Impact of Aetiological Treatment on Conventional and Multiplex Serology in Chronic Chagas Disease
Rodolfo Viotti et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Usefulness of PCR for monitoring benznidazole response in patients with chronic Chagas' disease: a prospective study in a non-disease-endemic country
Laura Murcia et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations
Constanca Carvalho Britto
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2009)
Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: The BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT)
Jose Antonio Marin-Neto et al.
AMERICAN HEART JOURNAL (2008)
Etiological treatment in patients infected by Trypanosoma cruzi:: experiences in Argentina
Sergio Sosa-Estani et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2006)
Polymerase chain reaction detection and serologic follow-up after treatment with benznidazole in Bolivian children infected with a natural mixture of Trypanosoma cruzi I and II
Maria Flores-Chavez et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2006)
Long-term cardiac outcomes of treating chronic chagas disease with benznidazole versus no treatment - A nonrandomized trial
Rodolfo Viotti et al.
ANNALS OF INTERNAL MEDICINE (2006)
Short report:: Benznidazole efficacy among Trypanosoma cruzi-infected adolescents after a six-year follow-up
ALSS Andrade et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2004)
Aetiological treatment of congenital Chagas' disease diagnosed and monitored by the polymerase chain reaction
AG Schijman et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
A critical review on Chagas disease chemotherapy
JR Coura et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2002)
Treatment of Trypanosoma cruzi-infected children with nifurtimox:: a 3 year follow-up by PCR
A Solari et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Progressive chronic Chagas heart disease ten years after treatment with anti-Trypanosoma cruzi nitroderivatives
L Lauria-Pires et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2000)
分享论文
